MAPT and Alzheimer disease: In a rat model of AD, N-acetyl-L-tryptophan leads to downregulation of inflammatory markers such as TNF-α and IL-6 in the hippocampus and frontal cortex, and reduces acetylcholinesterase activity, NF-κB, and total and phosphorylated tau protein levels.